Trauma-Informed Toolkit for HIV Prevention in African American Women
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop and test a new toolkit to help African American women in Mississippi effectively access HIV prevention services. The Trauma-Informed Toolkit focuses on Pre-Exposure Prophylaxis (PrEP), a medication that helps prevent HIV, and addresses barriers such as intimate partner violence that may hinder women from using PrEP. The goal is to create a supportive clinic environment sensitive to these challenges, ultimately reducing HIV rates among African American women. The trial seeks African American women currently receiving care at a community healthcare clinic in Mississippi. As an unphased trial, it offers participants the opportunity to contribute to innovative solutions that could significantly improve access to HIV prevention services.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this Trauma-Informed Toolkit is safe for use in HIV prevention?
Research has shown that trauma-informed methods can help prevent HIV. A toolkit based on these methods creates supportive spaces for individuals who have experienced trauma. Studies have found that incorporating trauma-informed care in clinics improves services for women at risk of HIV.
The toolkit specifically addresses the needs of African American women, particularly those facing intimate partner violence. It aids healthcare providers in better understanding and supporting these women in HIV prevention.
No reports of negative effects have emerged from using this toolkit. By focusing on enhancing communication and support rather than direct medical treatment, it appears to be well-received.12345Why are researchers excited about this trial?
The Trauma-Informed Toolkit is unique because it integrates the understanding of intimate partner violence with HIV prevention strategies specifically for African American women. Unlike other prevention methods that may not address the broader social and personal challenges these women face, this toolkit aims to create culturally-sensitive clinical environments. Researchers are excited about this approach because it equips healthcare providers with the skills to better support and prevent HIV in women who are also experiencing intimate partner violence, potentially leading to more effective and comprehensive care.
What evidence suggests that this Trauma-Informed Toolkit is effective for increasing Pre-Exposure Prophylaxis uptake among African American women?
Research shows that trauma-informed care can enhance HIV prevention, particularly for African American women at high risk for HIV who experience intimate partner violence. Studies indicate that addressing trauma in healthcare settings leads to better patient involvement and health outcomes. For instance, trauma-informed practices in clinics have created supportive environments that encourage women to start and continue using HIV prevention methods like Pre-Exposure Prophylaxis (PrEP). This approach aims to make healthcare more accessible and effective by considering the unique experiences and challenges these women face. In this trial, researchers are developing the Trauma-Informed Toolkit to specifically improve HIV prevention strategies for African American women in the South.12678
Who Is on the Research Team?
Tiara C. Willie, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Are You a Good Fit for This Trial?
This trial is for African American women receiving care at community healthcare clinics in Mississippi, who are at risk for HIV infection and may also be dealing with intimate partner violence. Participants must speak and understand English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Formative Evaluation
Key informant interviews with clinical staff and focus groups with African American women to inform the development of the Pre-Exposure Prophylaxis Implementation Toolkit
Toolkit Development and Pilot Testing
Development of the Pre-Exposure Prophylaxis Implementation Toolkit and pilot testing in two community healthcare clinics using a nonrandomized waitlist control design
Effectiveness Stage
Assessment of changes in Pre-Exposure Prophylaxis uptake and retention in care at the clinic level from 8-months before and after the Toolkit is implemented
Adoption Stage
Focus groups with clinical staff to assess barriers and facilitators to the Toolkit's adoption
Follow-up
Participants are monitored for retention in care and effectiveness of the Toolkit implementation
What Are the Treatments Tested in This Trial?
Interventions
- Trauma-Informed Toolkit
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor